- Collagen (Type II) -


  • The most abundant protein in the human body making up 70% to 90% total weight of all connective tissues.

  • There are 15 different types of collagen with type II being the most abundant collagen found in joint cartilage

  • Most gelatin products in the market today use hydrolyzed type I cartilage, which is found predominantly in the skin. There are no studies that show type I collagen has the ability to enhance production of joint cartilage

  • Collagen type II, not only functions as a joint re-building nutrient, but it also seems to have immune system modulating effects which help to curb the destructive process and lessen inflammation


Collagen is the most abundant protein in the body. It makes up about 30% of all proteins and is 70% to 90% total weight of all connective tissuesI. It is a fibrous protein, and derives its name from two Greek words; kolla meaning glue and gennan meaning to produce. So the word collagen means glue-former.


There are fifteen distinct types of collagen depending on the molecular structure.
Type I is found in ligaments, tendons, bone, and skin. Type II is the most predominant collagen found in cartilage along with types IX, X, XI, and XII. Type II is also found in the center of each vertebral disc, known as the nucleus pulposus.

Similar to the DNA’s double-helix structure, collagen is composed of three strands, or polypeptide chains, forming a triple-helix. Each of these chains is composed of three amino acids, usually glycine, proline, and hydroxyproline.

Cartilage is composed of proteoglycans, collagen, chondrocytes (cartilage cells), and water. Glucosamine (an amino-sugar composed of glucose and glutamine) is found in much larger molecules, known as glycosaminoglycans (GAGs). Chondroitin sulfate, which has found great popularity today in treating osteoarthritis, is a glycosaminoglycan. These GAGs are polysaccharides that form long chains. After they are formed they are attached to a core protein to make a proteoglycan subunit. These proteoglycan subunits are then attached by a link protein to a hyaluronic acid molecule (another, much larger glycosaminoglycan) to create a proteoglycan aggregate, which then takes on a bottlebrush-like appearance. These GAGs are highly electro-negatively charged and attract large numbers of positively charged ions, such as sodium (Na+ ), and being osmotically active, cause large amounts of water to be attracted to these tissues


This increase in water volume gives the cartilage matrix qualities of being able to withstand huge compressive and torqueing forces.
Proteoglycans take up approximately 1000 times more space when wet than when dryII.

Chondrocytes are responsible for creating, forming, and repairing cartilage. Although they have a very poor oxygen and food supply, they seem to produce large amounts of collagen and proteoglycansIII.

Recently there have been many gelatin products available today that claim to help restore damaged joint materials. However, most of these gelatin products are typically derived from skin and not from cartilage, thus most of the collagen available is type I. As of today, there has been no research to show that collagen type I is effective in treating any forms of arthritis.

Research on collagen type II is another story, however. In the first Harvard trial, Dr. Trentham administered very small doses of collagen type II (derived from chicken sternal cartilage) to ten of his patients who had been diagnosed with rheumatoid arthritis. Prior to beginning the study, he had all of his patients discontinue their immune suppressive and disease-modifying drugs (methotrexate, mercaptopurine, azathioprine, or auranofin). These patients were then given 0.1 mg of collagen daily for one month, and then 0.5 mg for the next two months. Clinical response was defined as a 50% or greater improvement in the number of swollen and tender joints, accompanied by a 50% or greater improvement in two additional measures (morning stiffness, 15-meter walking time, grip strength, Westergren erythrocyte sedimentation rate, or physician or patient global assessment), lasting for two months after the treatment period. Six of the ten patients showed substantial clinical response, and one showed a complete response lasting 26 months. There were no adverse effectsIV.

Following this study, and because of the favorable results of Dr. Trentham’s research, a 90-day double-blind, phase II placebo study was performed involving 60 patients with severe active rheumatoid arthritis. These patients received either the placebo or solubilized type II collagen at 0.1 mg for one month and then 0.5 mg for two months. At the end of the study, 59 of the patients were evaluated. Twenty eight of these had received the collagen type II and thirty one had received the placebo.


Compared with the placebo group, the collagen group showed significant improvements in joint swelling, tenderness or pain, and in 15-meter walking time at months 1, 2, and 3.
During the treatment time, those patients who had taken the collagen type II and were taken off of their immunosuppressive drugs, showed stability and or improvement, while those taking the placebo tended to get worse. Four patients in the collagen group showed complete resolution, while in the placebo group, no one showed remission. And again there were no side effectsV.

There are two schools of thought as to how collagen type II seems to have this positive effect. The first theory speaks of a process known as oral tolerization in which small quantities of antigens cause biological processes that suppress inflammation at the cellular level, suppress response to delayed-hypersensitivity antigens, and eliminate the cells that respond to antigens. As of today, other studies using chicken sternal cartilage as a source of collagen type II offer conflicting results. My feeling is that because this quite unique matrix, derived from chicken sternal cartilage, containing collagen, glucosamine (15%), and chondroitin sulfate (15%), it provides a very comprehensive formula of nutrients required to re-construct damaged tissues and also provide wonderful anti-inflammatory qualities.


Recent research has also shown that collagen type II contains a powerful antioxidant known as cartilage matrix glycoprotein (CMGP), a proteoglycan, which can also protect the joint from oxidative damageVI.
I Bucci, L, Nutrition Applied to Injury Rehabilitation and Sports Injury, CRC Press, Boca Raton, FL 1995, p10.

II Seaman, David R, Clinical Nutrition for Pain, Inflammation and Tissue Healing, NutrAnalysis, Inc, Hendersonville, NC, 1998, p151.

III Bucci L, Nutrition Applied to Injury Rehabilitation and Sports Injury, CRC Press, Boca Raton, FL 1995, p13.

IV Trentham DE. Oral tolerization as a treatment of rheumatoid arthritis, Rheum Dis Clin North Am, 1998; 24(3): 525-536.

V Medical Sciences Bulletin, Oral Collagen for Rheumatoid Arthritis, Pharmaceutical Information Associates, Ltd. April 25, 1997.

VI Duarte A, Collagen Type II and Arthritis; Is Collagen Type II A Help for Arthritis and Heart Disease?

About Dr. Cochran  •  About Serious Joint Nutrition  •  About Cetyl Myristoleate  •  Research Data  •  Contact Us  •  Home

Copyright © 2002, Innovative Naturals, LLC